Vaxart Inc (VXRT)
$0.57
0.18 (23.67%)
VXRT Stock Quote Delayed 30 Minutes
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth checking out on Friday as we dive into all of the biggest news moving shares this morning!
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
86.99M
PE Ratio
-3.37
EPS
-0.17
Volume (Avg. Vol.)
63.96M
Day's Range
$0.56 - $0.78
52-Week Range
$0.53 - $1.54
Dividend & Yield
N/A (N/A)
VXRT Stock Predictions, Articles, and Vaxart Inc News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage!
Why Is Vaxart (VXRT) Stock Down 25% Today?
Vaxart (VXRT) stock is taking a beating on Wednesday as investors react to the company announcing a proposed public share offering.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting the day off right with a breakdown of the biggest pre-market stock movers worth reading about on Wednesday!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!
What Is Going on With Vaxart (VXRT) Stock Today?
Vaxart released encouraging results for its oral Covid-19 vaccine, though sentiment for VXRT stock presently remains mixed.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning! We're starting off another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday!
Vaxart: Oral Covid-19 Vaccine Is Interesting, But Questions Linger
VXRT stock is more than a Covid-19 meme trade. But is there enough fundamentals there to support an investment heading into 2022?
Vaxart Deserves More Respect on Wall Street for Its Promising Covid-19 Vaccine
As the Covid-19 vaccine maker expands into a second manufacturing facility, VXRT stock remains an undervalued gem.
VXRT Stock: Other Vaccine Stocks Are Gaining But Jim Cramer Just Sent Vaxart Down
Despite a new factory acquisition, VXRT stock is down 9% on the day as 'Mad Money' host Jim Cramer warns investors about Vaxart.
Don’t Write Off Vaxart, As Its Oral Vaccine Still Has a Chance
VXRT stock is still worth a shot, as there's still big potential demand for a "no-needle" Covid-19 vaccine alternative.
Why Investing in VXRT Stock is a Coin Flip
Vaxart is a gamble for biotechnology investors, with its upside too dependent on the approval of an oral vaccine.
Vaccine Stocks: Why MRNA, VXRT, CVAC and NVAX Stocks Need a Band-Aid Today
Today, vaccine stocks are taking a massive hit as investors price in the potential effect of oral medications for Covid-19 on this sector.
Vaxart Traders Should Not Dismiss the Vaccine Maker’s Momentum
The recently range-bound price action of VXRT stock doesn't reflect the progress that Vaxart is making against Covid-19.
It’s Time to Start Thinking Seriously About Vaxart
While VXRT stock is risky due to underlying clinical challenges, the evolving nature of Covid-19 makes it worth consideration.
Vaxart Stock Is One Vaccine Also-Ran Worth Another Look
If you're looking to wager on a vaccine long-shot, place your bet on VXRT stock.
Is Vaxart Stock Really Worth a Shot?
VXRT stock still has hope as Vaxart is developing modern rDNA vaccines in pill form (including a Covid-19 vaccine), aiming to overcome needle challenges.
Longshot Covid Play Vaxart Stock Is Too Risky at These Prices
Vaxart got approval Aug. 2 for a Phase II trial for its oral Covid-19 vaccine. VXRT stock has gained 22% since. Should you buy on momentum?
Vaxart Is Another Risky Biotech Stock to Avoid Right Now
VRXT stock is highly overvalued. Investors are holding out for its Covid-19 vaccine, but it may not be approved in time to boost shares.
